Prevention of the Formation of Unaesthetic Scars Following the Surgical Cutaneous Wounds Healing of the Jaw and Facial Region Based on Transplantation of Xenogenic Fibroblasts

Marina N. Morozova, Alexey G. Baranovsky, Yelena Yu. Shapovalova, Svetlana A. Demyanenko, Yuri G. Baranovsky, Tatiana A. Boyko, Fedor N. Ilchenko

International Journal of Biomedicine. 2019;9(3):251-256.   
DOI: 10.21103/Article9(3)_OA13
Originally published September 15, 2019  


The purpose of this study was to optimize healing and prevent the formation of unaesthetic scars of the maxillofacial region by transplanting xenogenic dermal fibroblasts (XDFs) into a fresh surgical wound.
Materials and Methods: A total of 26 patients were selected with formations located on the skin of the face and neck, which could be compared with symmetrical areas of the healthy side. The patients were divided into 2 groups—the main group (Group 1) and the control group (Group 2). In Group 2 (n=12), a neoplasm was dissected, followed by grafting with local tissues, and in the Group 1 (n=14), a culture suspension of XDFs was injected by a tunnel method into the wound edges before stitching. The area of scar formation was determined using the LesionMeter program for the Android operating system. Contact thermography was carried out using thermo indicator films (CelluVision kit,  IPS  Italy).
Results: The analysis of the parameters of the young scar formation on Day 30 after the operation makes it possible to state that the introduction of cell culture of XDFs in the wound edges has a positive effect on the healing rate of surgical wounds, decreases the inflammatory response and contributes to the development of a distinctively positive scar in terms of its quality and functional characteristics. By Day 30, the primary surgical wound area was reduced by 67.69%, and 71.43% of patients had soft and thin aesthetic scars with microcirculation that were not distinguishable from the surrounding skin and the skin of symmetrical areas of the face or neck. In patients of the control group, without fibroblast transplantation, the area decreased by only 50.0% and aesthetic scars were formed only in 41.67% of cases. In 16.67% of patients, the presence of wide, dense, cold (due to weak vascularization) hypotrophic scars was noted. Hyperthermia persists around these scars, indicating a weak inflammatory response.
Conclusion: The use of a cell culture suspension of XDFs in the treatment of postoperative surgical wounds opens up new real possibilities for reducing the incidence of inflammatory reactions, stimulates healing processes and contributes to the development of more functionally and aesthetically acceptable scars on the face and neck.

surgical wound • fibroblasts • scar • planimetry • thermometry
  1. Broughton G, Janis JE, Attinger CE. The basic science of wound healing. Plast Reconstr Surg. 2006; 117(7 Suppl):12S–34S.
  2. Profyris C, Tziotzios C, Do Vale I. Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics Part I. The molecular basis of scar formation. J Am Acad Dermatol. 2012;66(1):1–10. doi: 10.1016/j.jaad.2011.05.055. 
  3. Bielefeld KA, Amini-Nik S, Alman BA. Cutaneous wound healing: recruiting developmental pathways for regeneration. Cell Mol Life Sci. 2013; 70(12):2059-81. doi: 10.1007/s00018-012-1152-9.
  4. Atiyeh BS, Amm CA, El Musa KA. Improved scar quality following primary and secondary healing of cutaneous wounds. Aesthetic Plast Surg. 2003;27(5):411–7. 
  5. Belousov AE. Scars and their correction. SPb.: "Commander-SPB"; 2005. [In Russian].
  6. Bock O, Schmid-Ott G, Malewski P, Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res. 2006; 297(10):433–8.
  7. Mofikoya BO, Adeyemo WL, Ugburo AO. An overview of biological basis of pathologic scarring. Niger Postgrad Med J. 2012;19(1):40–45.
  8. Agarwal C, Britton ZT, Alaseirlis DA, Li Y, Wang JHC. Healing and normal fibroblasts exhibit differential proliferation, collagen production, alpha-SMA expression, and contraction. Ann Biomed Eng. 2006;34(4):653–9.
  9. Carantino I, Florescu IP, Carantino A. Overview about the keloid scars and the elaboration of a non-invasive, unconventional treatment. J Med Life. 2010;3(2):122-7.
  10. Kolokol’tseva TD, Iurcnenko ND, Kolosov NG, Nechaeva EA, Shumakova OV, Khrtisto SA. [Prospects of use human fetal fibroblasts in the treatment of various etiology wounds]. Vestn Ross Akad Med Nauk. 1998;(3):32-5. [Article in Russian].
  11. Fang FHuang RLZheng YLiu MHuo R. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling. J Dermatol Sci. 2016;83(2):95-105. doi: 10.1016/j.jdermsci.2016.03.003.
  12. Namazi MR, Fallahzadeh MK, Schwartz RA. Strategies for prevention of scars: what can we learn from fetal skin? Int J Dermatol. 2011;50(1):85-93. doi: 10.1111/j.1365-4632.2010.04678.x.
  13. Li H, Fu X. Mechanisms of action of mesenchymal stem cells in cutaneous wound repair and regeneration. Cell Tissue Res. 2012;348(3):371-7. doi: 10.1007/s00441-012-1393-9.
  14. Lupatov AU, Vdovin AS, Vakhrushev IW, Poltavtseva RA, Yarygin KN. [Comparative analysis of the expression of surface markers on fibroblasts and fibroblast-like cells isolated from various human tissues]. Cell Technologies in Biology and Medicine. 2014;4:221-228. [Article in Russian].
  15. Luo L, Li J, Liu H, Jian X,  Zou Q, Zhao Q, et al. Adiponectin is involved in connective tissue growth factor-induced proliferation, migration and overproduction of the extracellular matrix in keloid fibroblasts. Int J Mol Sci. 2017; 18(5). pii: E1044. doi: 10.3390/ijms18051044.
  16. Wilgus TA. Regenerative healing in fetal skin: a review of the literature. Ostomy Wound Manage. 2007;53(6):16–31.
  17. Walmsley GG, Maan ZN, Hu MS, Atashroo DA, Whittam AJ, Duscher D, et al.  Murine dermal fibroblast isolation by FACS.  J Vis Exp. 2016;(107):53430. doi: 10.3791/53430.
  18. Ogawa R. Surgery for scar revision and reduction: from primary closure to flap surgery. Burns Trauma. 2019;7:7. doi: 10.1186/s41038-019-0144-5.
  19. Seo BF, Jung SN. The immunomodulatory effects of mesenchymal stem cells in prevention or treatment of excessive scars. Stem Cells Int. 2016;2016: 6937976. doi: 10.1155/2016/6937976.
  20. Liu J, Ren J, Su L, Cheng S, Zhou J, Ye X, et al. Human adipose tissue-derived stem cells inhibit the activity of keloid fibroblasts and fibrosis in a keloid model by paracrine signaling. Burns. 2018;44(2):370-385. doi: 10.1016/j.burns.2017.08.017.
  21. Esfahani M, Movahedian A, Baranchi M. Adiponectin: an adipokine with protective features against metabolic syndrome. Iran J Basic Med Sci. 2015;18(5):430–42.
  22. Shapovalova YeYu, Boyko TA, Baranovskiy YuG, Morozova MN, Barsukov NP, Ilchenko FN, et al. Effects of fibroblast transplantation on the content of macrophages and the morphology of regenerating ischemic cutaneous wounds. International Journal of Biomedicine. 2017;7(4):302-306.
  23. Petrov VV. [Age-related changes in the number of CD45+ cells in human dermis]. Adv Gerontol. 2012;25(4):598–603. [Article in Russian].
  24. Itoh Y, Arai K. Use of recovery-enhanced thermography to localize cutaneous perforators. Ann Plast Surg. 1995;34(5):507-11.
  25. Renkielska A, Nowakowski A, Kaczmarek M, Dobke MK, Grudziński J, Karmolinski A, et al. Static thermography revisited – an adjunct method for determining the depth of the burn injury. Burns. 2005;31(6):768-75.

Download Article
Received May 11, 2019.
Accepted July 14, 2019.
©2019 International Medical Research and Development Corporation.